Letter to the Editor

PCC
Psychosis Screening in Genetic Disorders
Letter to the Editor

December 4, 2025

The author discusses routine monitoring for the development of psychotic symptoms among individuals with rare genetic disorders that confer risk for psychosis.
PCC
Culturally Adaptive Mental Health Care
Letter to the Editor

December 2, 2025

The author discusses the culturally adaptive work of Dr Vidya Sagar, whose mid-20th-century innovations in family-centered care laid the groundwork for India’s unique trajectory in community psychiatry.
JCP
Burnout in Psychiatric Doctors Before and After COVID-19: A Critical Commentary
Letter to the Editor

December 1, 2025

The authors comment on a recent meta-analysis by Johnson and colleagues.
,
JCP
Exposure Therapy for Perinatal OCD: Navigating Evidence and Discomfort
Letter to the Editor

November 17, 2025

Although patients and providers must be prepared for the temporary distress associated with exposure and response prevention, it remains the most effective nonpharmacologic treatment for OCD.
, ,
JCP
From Today’s Observations to Tomorrow’s Standards in Women’s Psychiatry
Letter to the Editor

November 3, 2025

The authors comment on a recent study of treatment use and preference in women with mood disorders.
, ,
JCP
Context Matters in Treatment Preference of Women With Mood Disorders: Reply to Świeczkowski et al
Letter to the Editor

November 3, 2025

The authors reply to Świeczkowski and colleagues’ letter regarding their recent study
,
JCP
Racemic Ketamine vs Esketamine in Treatment-Resistant Depression: The Overlooked Role of Arketamine
Letter to the Editor

October 29, 2025

The authors comment on a recent chart review by Meisner et al.
,
PCC
Brain Injuries, Illness, and Treatment in Sports
Letter to the Editor

October 2, 2025

In their letter to the editor, the authors discuss the need for sports psychiatry and neurology to be viewed as a central part of the sports medicine field.
,
PCC
Complicated Grief: Is There a Role for Naltrexone?
Letter to the Editor

September 23, 2025

The authors discuss prolonged grief disorder and the use of medications like naltrexone as a potential treatment.
,
PCC
Knowledge of ECT for Catatonia
Letter to the Editor

September 11, 2025

The authors comment on a recent study by Kaur et al assessing what internists and neurologists know about catatonia.
,
PCC
Knowledge of Catatonia: Reply to Espinoza and Kellner
Letter to the Editor

September 11, 2025

The authors reply to a letter to the editor commenting on their article.
, , , et al
JCP
Misleading Labeling of S-Methadone as a Novel N-Methyl-D-Aspartate Receptor Antagonist
Letter to the Editor

September 8, 2025

The authors comment on a recent study by Fava et al showing clinical evidence for a long-term antidepressant effect of esmethadone.
,
JCP
Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant: Reply to Ferré and Michaelides
Letter to the Editor

September 8, 2025

The authors reply to Ferré and Michaelides’ letter commenting on their recent study of long-term esmethadone treatment in MDD.
, , , et al
JCP
Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al
Letter to the Editor

September 1, 2025

The authors reply to a letter by Modesto-Lowe et al regarding their survey of psychedelic practitioners’ views on psychological support.
, , , et al
JCP
Toward Consensus in Psychedelic-Assisted Therapy: The Critical Role of Psychotherapeutic Support
Letter to the Editor

September 1, 2025

A recent survey examining psychedelic practitioners’ views on psychological support in psychedelic-assisted therapy is discussed.
, ,
JCP
Suicide Risk among Patients with Bipolar Disorder: Sleep Disruption versus Benzodiazepine Use
Letter to the Editor

July 28, 2025

The authors comment on a recent study by Saulnier et al of benzodiazepines and suicide among Veterans with bipolar disorder.
,
PCC
Reversible Cerebral Vasoconstriction Syndrome and Marijuana
Letter to the Editor

July 22, 2025

The authors raise awareness of a potential complication of extensive marijuana use.
, ,
PCC
Onco-Psychopharmacology: Is Mirtazapine a Catholicon?
Letter to the Editor

June 24, 2025

The author discusses the role of mirtazapine in the treatment of depression in patients with cancer.
PCC
Community-Based Alternatives in Behavioral Crisis Transport
Letter to the Editor

June 12, 2025

Law enforcement transport for individuals in behavioral health crises results in significant financial costs and psychological trauma, reinforcing criminalization and stigma while worsening mental health conditions.
,
JCP
Erecting Barriers to Suicide by Removing Barriers to Science
Letter to the Editor

April 30, 2025

The authors comment on the implications of a recent NSF communication warning researchers about the use of certain terms in grant proposals and publications made possible with government funding.
, , , et al
PCC
Revisiting Ayahuasca: Vine of the Soul of the Amazon
Letter to the Editor

March 18, 2025

The authors comment on a case report previously published in the PCC describing psychosis and ayahuasca use and discuss the need for further research given its increased usage worldwide.
,
PCC
Cannabis Withdrawal Psychosis
Letter to the Editor

March 13, 2025

Dr Gorelick comments on a case report recently published in the PCC.
PCC
Cannabis Withdrawal Psychosis: Reply to Gorelick
Letter to the Editor

March 13, 2025

The authors reply to a letter to the editor commenting on their case report.
,
PCC
Parenting Young Adults With ADHD
Letter to the Editor

February 13, 2025

The authors explore the role of parental involvement in supporting young adults with ADHD.
, ,

Consensus Report on XT Use in Practice

Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe